In a survey of 141 patients with rheumatoid arthritis, 63% indicated a preference for the administration of medication intravenously (IV) and 37% indicated a preference for administration subcutaneously (SC). *Preferred someone else to inject the medication. †Preferred self-injection. Adapted, with permission, from .
Schwartzman and Morgan Arthritis Res Ther 2004 6(Suppl 2):S19-S23 doi:10.1186/ar996